Coronation Fund Managers Ltd. Raises Position in GE HealthCare Technologies Inc. $GEHC

Key Points

• Coronation Fund Managers Ltd. increased its stake in GE HealthCare Technologies by 1.5% during the second quarter, now owning 342,547 shares valued at approximately $25.37 million.
• Recent analyst ratings reveal a mixed outlook for GE HealthCare Technologies, with a consensus rating of "Moderate Buy" and a target price of $85.20.
• GE HealthCare Technologies announced a quarterly dividend of $0.035 per share, representing an annualized yield of 0.2% to shareholders of record on October 24th.

Coronation Fund Managers Ltd. boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 1.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 342,547 shares of the company's stock after buying an additional 5,225 shares during the period. GE HealthCare Technologies accounts for approximately 1.4% of Coronation Fund Managers Ltd.'s portfolio, making the stock its 23rd largest position. Coronation Fund Managers Ltd. owned 0.07% of GE HealthCare Technologies worth $25,372,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the business. Whittier Trust Co. of Nevada Inc. lifted its position in GE HealthCare Technologies by 2.8% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 82,087 shares of the company's stock valued at $6,079,000 after acquiring an additional 2,226 shares during the period. Whittier Trust Co. lifted its stake in shares of GE HealthCare Technologies by 2.0% in the second quarter. Whittier Trust Co. now owns 132,597 shares of the company's stock worth $9,820,000 after buying an additional 2,550 shares in the last quarter. DekaBank Deutsche Girozentrale lifted its stake in shares of GE HealthCare Technologies by 0.6% in the second quarter. DekaBank Deutsche Girozentrale now owns 54,371 shares of the company's stock worth $4,054,000 after buying an additional 341 shares in the last quarter. CMG Global Holdings LLC bought a new position in shares of GE HealthCare Technologies in the second quarter worth approximately $1,329,000. Finally, Community Bank of Raymore lifted its stake in shares of GE HealthCare Technologies by 11.8% in the second quarter. Community Bank of Raymore now owns 14,207 shares of the company's stock worth $1,052,000 after buying an additional 1,500 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on GEHC. Barclays began coverage on shares of GE HealthCare Technologies in a research note on Monday, October 13th. They issued an "equal weight" rating and a $86.00 target price on the stock. Weiss Ratings reiterated a "hold (c+)" rating on shares of GE HealthCare Technologies in a research note on Tuesday, October 14th. Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, September 18th. Citigroup downgraded shares of GE HealthCare Technologies from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $93.00 to $83.00 in a research note on Tuesday, October 7th. Finally, BTIG Research boosted their price objective on shares of GE HealthCare Technologies from $87.00 to $89.00 and gave the company a "buy" rating in a report on Monday, October 13th. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $85.20.

GE HealthCare Technologies Stock Up 1.9%

Shares of GEHC stock opened at $75.48 on Tuesday. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The stock has a market cap of $34.46 billion, a P/E ratio of 15.47, a P/E/G ratio of 2.83 and a beta of 1.13. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The company has a 50 day simple moving average of $74.56 and a two-hundred day simple moving average of $72.13.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, beating analysts' consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business had revenue of $5 billion during the quarter, compared to analysts' expectations of $4.96 billion. During the same period in the prior year, the company earned $1.00 earnings per share. The firm's revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies's dividend payout ratio is currently 2.87%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.